- Home
- BPOP vs KRYS Comparison
BPOP vs KRYS Comparison
Compare BPOP & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | KRYS |
|---|---|---|
| Founded | 1893 | 2015 |
| Country | United States | United States |
| Employees | 9406 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 7.8B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | BPOP | KRYS |
|---|---|---|
| Price | $131.52 | $257.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $148.60 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 469.7K | 244.8K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 6.84 |
| Revenue | N/A | ★ $389,130,000.00 |
| Revenue This Year | $11.33 | $40.88 |
| Revenue Next Year | $6.02 | $35.16 |
| P/E Ratio | ★ $11.87 | $37.51 |
| Revenue Growth | N/A | ★ 33.94 |
| 52 Week Low | $78.23 | $123.03 |
| 52 Week High | $149.31 | $298.30 |
Technical Indicators
Market Signals| Indicator | BPOP | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 44.40 |
| Support Level | $122.73 | $233.64 |
| Resistance Level | $149.23 | $293.60 |
| Average True Range (ATR) | 4.04 | 9.04 |
| MACD | -0.88 | -1.50 |
| Stochastic Oscillator | 31.35 | 31.60 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.